Global Live Cell Imaging Market Segmentation, By Product and Service (Instruments, Consumables, Software, Services), Application (Cell Biology, Stem Cells, Developmental Biology, Drug Discovery), End-Users (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Contract Research Organizations), Technology (Time Lapse Microscopy, Fluorescence Recovery After Photo Bleaching, High Content Screening, Fluorescence Resonance Energy Transfer, Others) – Industry Trends and Forecast to 2032
Live Cell Imaging Market Analysis
The live cell imaging market is expected to expand, during the forecast period. Live cell imaging is a technique that allows scientists to investigate cells, their structures, functions, and properties in real time. The approach has revolutionised research into molecular interactions, cells, proteins, and a wide range of activities. Because live cell imaging is less susceptible to experimental artefacts than fixed cell imaging, the market for live cell imaging has a solid platform on which to build.
Live Cell Imaging Market Size
Global live cell imaging market size was valued at USD 4.59 billion in 2024 and is projected to reach USD 10.13 billion by 2032, with a CAGR of 10.40% during the forecast period of 2025 to 2032.
Report Scope and Market Segmentation
|
Attributes
|
Live Cell Imaging Key Market Insights
|
|
Segmentation
|
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Key Market Players
|
Bio-Rad Laboratories, Inc. (U.S), Agilent Technologies (U.S), Cytiva (U.S), Blue-Ray Biotech Corp. (Taiwan), CytoSMART Technologies (Netherlands), Curiosis Inc. (South Korea), Carl Zeiss AG (U.S), General Electric (U.S), Leica Microsystems (Germany), Thermo Fisher Scientific Inc. (U.S), Perkin Elmer (U.S), Danaher (U.S), Bruker (U.S), Nikon Corporation (Japan), and Olympus Corporation (Japan)
|
Live Cell Imaging Market Definition
The study of cells in real time using pictures obtained from screening devices and microscopes is known as live cell imaging. Scientists' approaches to studying proteins, molecular interactions, and internal structures of cells, as well as cellular processes and biological activities, have changed as a result of technological advancements. Instead of reviewing the photos of fixed cells, they can watch cells to acquire a more in-depth insight.
Live Cell Imaging Market Dynamics
Drivers
- Increasing research and development activities
Increasing research and development investment is likely to boost market growth. Other factors such as rising cancer incidence, rising adoption of high-content screening approaches in drug discovery, increasing demand for better and faster diagnostic facilities, and technological advancement are likely to propel the live cell imaging market forward from 2025 to 2032.
- Approval of high-content screening techniques
The adoption of high-content screening techniques, large government funding for cell-based research, and rising cancer occurrences worldwide are driving the global live cell imaging market. Market players can benefit from the adoption of high-content screening methods for primary screening and the use of live cell imaging in personalised medicine.
- Advancement Technologies
According to a poll conducted by Drug Discovery World Spring, nearly 21% of researchers favour and employ live cell imaging, with 31% planning to do so in the future. Furthermore, 38% of respondents said they would like to use live cell kinetic HCS imaging in the future. The capacity to automate the incubation and picture capture of any live cell analyser is the most significant feature for researchers. Second, they place a premium on the equipment's ability to track live cells. Over the projected period, more advancements in equipment technology are likely to meet these criteria and increase their utility.
Opportunities
The UK and Europe will face a major lack of lab skills over the next decade, according to Healthcare-in-Europe.com, an online platform that delivers trends in medical technology, new procedures, and breakthroughs in medical research. Medical laboratories will be among the most affected. Furthermore, according to the Gatsby Foundation's analysis, the UK will require an additional 700,000 technicians to sustain the economy by the end of 2030. As a result, in the next years, a scarcity of experienced workers is projected to stifle market expansion.
Restraints/Challenges
High cost of the high-content screening systems and lack of skilled and trained professionals is expected to hinder the market growth in the forecast period of 2025 to 2032.
This live cell imaging market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the live cell imaging market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Live Cell Imaging Market Scope
The live cell imaging market is segmented on the basis of product, application and technology. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Equipment
- Consumable
- Software
Application
- Cell Biology
- Developmental Biology
- Stem Cell and Drug Discovery
- Others
Technology
- Time-lapse Microscopy
- Fluorescence recovery after photobleaching (FRAP)
- Fluorescence resonance energy transfer (FRET)
- High content screening (HCS)
- Others
Live Cell Imaging Market Regional Analysis
The live cell imaging market is analyzed and market size insights and trends are provided by country, product, application and technology as referenced above.
The countries covered in the live cell imaging market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominated due to its high investment rate and technologically sound infrastructure. The research firms present in this region are technologically aware, hence, readily invest in high-cost equipment.
Asia-Pacific is expected to show the fastest growth over the forecast period due to the growing application of these imaging techniques in drug discovery and personalized medicine.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Live Cell Imaging Market Share
The live cell imaging market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to live cell imaging market.
Live Cell Imaging Market Leaders Operating in the Market Are:
- Bio-Rad Laboratories, Inc. (U.S)
- Agilent Technologies (U.S)
- Cytiva (U.S)
- Blue-Ray Biotech Corp. (Taiwan)
- CytoSMART Technologies (Netherlands)
- Curiosis Inc. (South Korea)
- Carl Zeiss AG (U.S)
- General Electric (U.S)
- Leica Microsystems (Germany)
- Thermo Fisher Scientific Inc. (U.S)
- Perkin Elmer (U.S)
- Danaher (U.S)
- Bruker (U.S)
- Nikon Corporation (Japan)
- Olympus Corporation (Japan)
Latest Developments in Live Cell Imaging Market
- In December 2020, Horizon Discovery was purchased for an unknown sum by PerkinElmer Inc., a US-based diagnostics company with detection, imaging, informatics, and service capabilities
SKU-